List of Excipients in API VEPDEGESTRANT
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing VEPDEGESTRANT
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Arvinas Operations Inc | VEPPANU | vepdegestrant | 84043-100 | CELLULOSE, MICROCRYSTALLINE | 2031-05-01 |
| Arvinas Operations Inc | VEPPANU | vepdegestrant | 84043-100 | CROSCARMELLOSE SODIUM | 2031-05-01 |
| Arvinas Operations Inc | VEPPANU | vepdegestrant | 84043-100 | FD&C BLUE NO. 2 | 2031-05-01 |
| Arvinas Operations Inc | VEPPANU | vepdegestrant | 84043-100 | FERRIC OXIDE YELLOW | 2031-05-01 |
| Arvinas Operations Inc | VEPPANU | vepdegestrant | 84043-100 | FERROSOFERRIC OXIDE | 2031-05-01 |
| Arvinas Operations Inc | VEPPANU | vepdegestrant | 84043-100 | GLYCERYL MONO- AND DICAPRYLOCAPRATE | 2031-05-01 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for VEPDEGESTRANT
Excipient focus: CELLULOSE, MICROCRYSTALLINE
VEPDEGESTRANT drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Arvinas Operations Inc | vepdegestrant | 84043-100 |
| >Company | >Ingredient | >NDC |
VEPDEGESTRANT drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
VEPDEGESTRANT drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Arvinas Operations Inc | vepdegestrant | 84043-100 |
| >Company | >Ingredient | >NDC |
VEPDEGESTRANT drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
VEPDEGESTRANT drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Arvinas Operations Inc | vepdegestrant | 84043-100 |
| >Company | >Ingredient | >NDC |
VEPDEGESTRANT drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
VEPDEGESTRANT drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Arvinas Operations Inc | vepdegestrant | 84043-100 |
| >Company | >Ingredient | >NDC |
VEPDEGESTRANT drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
VEPDEGESTRANT drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Arvinas Operations Inc | vepdegestrant | 84043-100 |
| >Company | >Ingredient | >NDC |
VEPDEGESTRANT drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONO- AND DICAPRYLOCAPRATE
VEPDEGESTRANT drug variants containing GLYCERYL MONO- AND DICAPRYLOCAPRATE
| Company | Ingredient | NDC |
|---|---|---|
| Arvinas Operations Inc | vepdegestrant | 84043-100 |
| >Company | >Ingredient | >NDC |
VEPDEGESTRANT drug variants not containing GLYCERYL MONO- AND DICAPRYLOCAPRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
VEPDEGESTRANT drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Arvinas Operations Inc | vepdegestrant | 84043-100 |
| >Company | >Ingredient | >NDC |
VEPDEGESTRANT drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
VEPDEGESTRANT drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Arvinas Operations Inc | vepdegestrant | 84043-100 |
| >Company | >Ingredient | >NDC |
VEPDEGESTRANT drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
VEPDEGESTRANT drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Arvinas Operations Inc | vepdegestrant | 84043-100 |
| >Company | >Ingredient | >NDC |
VEPDEGESTRANT drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER
VEPDEGESTRANT drug variants containing POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Arvinas Operations Inc | vepdegestrant | 84043-100 |
| >Company | >Ingredient | >NDC |
VEPDEGESTRANT drug variants not containing POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
VEPDEGESTRANT drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Arvinas Operations Inc | vepdegestrant | 84043-100 |
| >Company | >Ingredient | >NDC |
VEPDEGESTRANT drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
VEPDEGESTRANT drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Arvinas Operations Inc | vepdegestrant | 84043-100 |
| >Company | >Ingredient | >NDC |
VEPDEGESTRANT drug variants not containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
VEPDEGESTRANT drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Arvinas Operations Inc | vepdegestrant | 84043-100 |
| >Company | >Ingredient | >NDC |
VEPDEGESTRANT drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
VEPDEGESTRANT drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Arvinas Operations Inc | vepdegestrant | 84043-100 |
| >Company | >Ingredient | >NDC |
VEPDEGESTRANT drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: VITAMIN E POLYETHYLENE GLYCOL SUCCINATE
VEPDEGESTRANT drug variants containing VITAMIN E POLYETHYLENE GLYCOL SUCCINATE
| Company | Ingredient | NDC |
|---|---|---|
| Arvinas Operations Inc | vepdegestrant | 84043-100 |
| >Company | >Ingredient | >NDC |
VEPDEGESTRANT drug variants not containing VITAMIN E POLYETHYLENE GLYCOL SUCCINATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch